Clinical Snippets  by unknown
clinical snippets
© 2009 The Society for Investigative Dermatology www.jidonline.org 1051
Mediated by 
Antibodies
Expression of bullous 
pemphigoid antigen 2 
(hBPAG2) in skin grafts elicits an 
IgG response and subsequent 
graft loss. Lanschuetzer and 
colleagues demonstrated that 
CD40L, a molecule that plays a 
critical role in T-cell-mediated 
humoral immune responses, is 
required for this anti-basement 
membrane IgG production 
following skin grafts from 
hBPAG2-expressing transgenic 
mice. Costimulatory blockade 
with a CD40L antibody 
specifically precluded this 
IgG response and skin graft 
rejection. Importantly, the 
treatment facilitated long-term 
acceptance of the transgenic 
skin grafts and prevented loss 
of a second hBPAG2 transgenic 
skin graft. These results support 
the premise that the graft loss is 
mediated by antibodies.  
See page 1203
Micro Markers
MicroRNAs (miRNAs) regulate 
cellular processes via binding 
mRNAs to repress translation 
or increase degradation. 
Because these miRNAs may 
be considered a new class 
of oncogenes, development 
of miRNA biomarkers for 
specific cancer stages and 
prognoses is enticing. Glud 
and colleagues found that 
formalin-fixed, paraffin-
embedded melanocytic nevi 
were indeed suitable for 
miRNA profiling studies. This 
finding is important because 
surgical specimens have 
been stored in this format 
for decades and thus will be 
useful for the investigation of 
miRNA. See page 1219
In Through the Hair Follicle
New strategies for improving the effectiveness 
and delivery of vaccines include transcutaneous 
vaccine application and the use of nanoparticle 
(NP) compounds. Mahe and colleagues deter-
mined that both NPs and particulate viral vac-
cines penetrated the skin following tape stripping. 
Furthermore, confocal microscopy revealed that 
these particles penetrated the hair follicle, were 
taken up by antigen-presenting cells, and migrat-
ed to local lymph nodes. Both humoral and cel-
lular immune responses occurred in response to 
these NP vaccines, supporting the consideration 
of these strategies in future vaccination develop-
ment. See page 1156
Thyroid-to-Hair Communication
Endocrine abnormalities, including thyroid dis-
orders, are associated with alterations in skin 
and hair structure and function. Examination of 
the levels and functionality of thyroid-stimulat-
ing hormone (TSH) in human scalp hair follicles 
revealed that TSH receptors were expressed 
exclusively in the mesenchyme. Although treat-
ment of these cells with TSH did not affect hair 
growth, mesenchyme proliferation, or thyroid 
hormone secretion, this treatment stimulated 
cAMP secretion, which signifies activation of 
TSH receptors, and also upregulated the tran-
scription of the TSH target genes thyroglobin and thyroid transcription factor-1. These 
results highlight TSH receptor signaling as a critical active neuroendocrine pathway in 
extrathyroidal human skin. See page 1126
From Diabetes to Melanoma
Because the activation of peroxisome prolif-
erator-activated receptor-γ (PPARγ) has been 
implicated in melanoma inhibition, Botton and 
colleagues investigated the effects of thiazoli-
dinedione ligands, which are commonly used 
to treat non-insulin-dependent type 2 diabetes, 
on melanoma cell lines. Ciglitazone induced 
G0/G1 arrest and activation of PPARγ at low 
doses and resulted in apoptosis in a PPARγ-
independent fashion at high doses. Interestingly, 
although ciglitazone inhibited cell growth 
and viability of melanoma cell lines, the drug 
did not affect normal melanocytes. In vivo short-term treatment with ciglitazone 
reduced or abolished the development of melanoma tumors in mice. Thus, the anti-
melanoma effects of ciglitazone may promote the use of this drug in the clinical 
treatment of melanoma. See page 1208
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